Each cycle outputs a 400-tip dissolving delivery array. No injection. No sharps at point of application.
Vacuum-loaded at −0.65 bar. Thermally cured at 45°C ±1°C. Batch-to-batch consistency that manual formulation cannot match.
Compound, dose, and timing configured per patient at point of care. No pre-manufactured inventory.
Proprietary biopolymer blend. Factory-sealed, sterile, human-safe. You supply the API — Autonom does the rest.
First units Q3 2026. Pharmacies, clinics, research labs, and platform partners.